相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma
Eric A. Mellon et al.
ACTA ONCOLOGICA (2015)
Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
Cristina R. Ferrone et al.
ANNALS OF SURGERY (2015)
Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience
Ulrich Nitsche et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort
Daniel Pietrasz et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Salvage Pancreaticoduodenectomy After Complete Response to Chemoradiotherapy for a Previously Unresectable Pancreatic Adenosquamous Carcinoma A Case Report
Anne Elias et al.
MEDICINE (2015)
Safety and Efficacy of Modified FOLFIRINOX for Advanced Pancreatic Adenocarcinoma: A UK Single-Centre Experience
Ehsan Ghorani et al.
ONCOLOGY (2015)
Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma
Moh'd Khushman et al.
PANCREATOLOGY (2015)
Complete radiological response of an initially locally advanced unresectable pancreatic cancer to chemoradiotherapy using FOLFIRINOX regimen: Report of a case
Kathleen Turner et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)
Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas
Marlo Blazer et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
FOLFIRINOX for Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: The Royal Marsden Experience
Sing Yu Moorcraft et al.
CLINICAL COLORECTAL CANCER (2014)
Pancreatic Adenocarcinoma, Version 2.2014 Featured Updates to the NCCN Guidelines
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Neoadjuvant FOLFIRINOX Application in Borderline Resectable Pancreatic Adenocarcinoma A Retrospective Cohort Study
Alessandro Paniccia et al.
MEDICINE (2014)
Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreas Cancer: A New Treatment Paradigm?
Kathleen K. Christians et al.
ONCOLOGIST (2014)
Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature
S. Valeri et al.
PANCREATOLOGY (2014)
Borderline resectable pancreatic cancer: Definitions and management
Nicole E. Lopez et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy
S. Lorenzen et al.
ANNALS OF ONCOLOGY (2013)
Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer
V. Heinemann et al.
ANNALS OF ONCOLOGY (2013)
Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Cancer
Hidenori Takahashi et al.
ANNALS OF SURGERY (2013)
Induction gemcitabine and oxaliplatin therapy followed by a twice-weekly infusion of gemcitabine and concurrent external-beam radiation for neoadjuvant treatment of locally advanced pancreatic cancer
Francesco Leone et al.
CANCER (2013)
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer
Edward J. Kim et al.
CANCER (2013)
Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer
Brian A. Boone et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity
Krishna S. Gunturu et al.
MEDICAL ONCOLOGY (2013)
Complete Pathological Remission of Locally Advanced, Unresectable Pancreatic Cancer (LAPC) after Intensified Neoadjuvant Chemotherapy
Ingo Hartlapp et al.
ONKOLOGIE (2013)
Modified FOLFIRINOX Regimen With Improved Safety and Maintained Efficacy in Pancreatic Adenocarcinoma
Hemchandra Mahaseth et al.
PANCREAS (2013)
Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases
Jose Galindo et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy
Giuliano Barugola et al.
AMERICAN JOURNAL OF SURGERY (2012)
Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis
Qing Zhao et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2012)
Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
T. Seufferlein et al.
ANNALS OF ONCOLOGY (2012)
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
Peter J. Hosein et al.
BMC CANCER (2012)
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
Matthew H. G. Katz et al.
CANCER (2012)
Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies
Hiroshi Haeno et al.
CELL (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
Potential Contribution of Preoperative Neoadjuvant Concurrent Chemoradiation Therapy on Margin-Negative Resection in Borderline Resectable Pancreatic Cancer
Chang Moo Kang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer
Jayme B. Stokes et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S. Cascinu et al.
ANNALS OF ONCOLOGY (2010)
Unresectable Locally Advanced Pancreatic Cancer: A Multimodal Treatment Using Neoadjuvant Chemoradiotherapy (Gemcitabine Plus Stereotactic Radiosurgery) and Subsequent Surgical Exploration
Francesco Polistina et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Defining Venous Involvement in Borderline Resectable Pancreatic Cancer
Yun Shin Chun et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
Sonja Gillen et al.
PLOS MEDICINE (2010)
Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
Mark P. Callery et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma
Michele Reni et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Borderline resectable pancreatic cancer: Definitions, management, and role of preoperative therapy
Gauri R. Varadhachary et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer
RR White et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer -: A Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer Study
T Conroy et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Complete pathologic responses to preoperative chemoradiation in two patients with adenocarcinoma of the pancreas
V Magnin et al.
PANCREAS (2004)
Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma
V Moutardier et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer
V Magnin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
分享论文
